Type 2 Diabetes Mellitus

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes [Phase 4]

Phase 4 trial comparing metformin extended-release to metformin immediate-release in type 2 diabetes has completed with results posted.

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects [Phase 1]

This Phase 1 trial update evaluates the pharmacokinetic interaction when simvastatin is coadministered with PEX168 in healthy adult subjects…

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional

A completed pilot study evaluating glucose variability using the Abbott Sensor Based Glucose Monitoring System - Professional in individuals…

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control [Phase 4]

This clinical trial update reports the completion of a 2-year Phase 4 study evaluating cardiovascular diagnostics and metabolic control in p…

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Accuracy Characterization Study

Abbott Diabetes Care reports results from an accuracy characterization study involving people with type 1 and type 2 diabetes.

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Metabolic Effects of Stevia in Type 2 Diabetic Patients [NA]

Completed clinical trial evaluating the metabolic effects of Stevia (steviol glycosides) in adults with Type 2 diabetes mellitus.

CLINICAL_TRIALS research · 2017-01-24

Clinical Trial Update: Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin [Phase 3]

Phase 3 clinical trial update evaluating PEX168 in combination with metformin for type 2 diabetes mellitus; no results reported yet.

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients [Phase 3]

This document provides an update on the Phase 3 efficacy and safety study of PEX168 as monotherapy in adults with type 2 diabetes mellitus.

CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study [NA]

A completed pilot study evaluating personalized health planning in shared medical appointments for individuals with Type 2 diabetes mellitus…

CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus [Phase 3]

A Phase 3 clinical trial evaluating rosiglitazone for type 2 diabetes mellitus, including assessment of arterial plaque, has completed. Spon…

CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin [Phase 1]

A Phase 1 study assessing NN1250 in adults with type 2 diabetes across diverse races/ethnic origins has completed.

CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355) [Phase 4]

Phase 4 trial update evaluating the efficacy of sitagliptin and glibenclamide on glucose variability in Japanese participants with type 2 di…

CLINICAL_TRIALS research · 2017-01-23

Clinical Trial Update: A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes [Phase 1]

This Phase 1 trial, sponsored by Novo Nordisk, investigates the impact of nocturnal hypoglycemia on sleep in adults with Type 2 diabetes; th…

CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus [Phase 3]

Phase 3 trial comparing insulin degludec/liraglutide combination versus insulin glargine in adults with type 2 diabetes; completed with resu…

CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes [Phase 3]

A Phase 3 trial comparing the efficacy and safety of insulin degludec/liraglutide versus insulin degludec in adults with type 2 diabetes; co…

CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes [Phase 1]

A Phase 1 study evaluating the blood glucose-lowering effect of NN1250 in subjects with Type 2 diabetes has completed its Phase 1 assessment…

CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification [Phase 3]

Phase 3 trial comparing sequential addition of insulin aspart versus further dose escalation of the fixed-dose combination insulin degludec/…

CLINICAL_TRIALS research · 2017-01-20

Clinical Trial Update: Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy [EARLY_Phase 1]

An early-phase clinical study of Tang Wang Prescription aimed at intervening in diabetic non-proliferative retinopathy is reported.

CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI [Phase 2]

A completed Phase 2 trial investigating the prevalence of pancreatic exocrine insufficiency in Type 2 diabetes patients and how a single dos…

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects [Phase 1]

A Phase 1 clinical trial update reports on the safety and metabolic profile of the investigational compound GSK376501 in overweight adults w…

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin [Phase 3]

A Phase 3 trial comparing two insulin pen delivery systems in patients with diabetes treated with insulin has completed.

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients

A completed French observational survey by Novo Nordisk assessing hypoglycemia in patients treated with insulin for diabetes. The study incl…

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus [NA]

A completed clinical trial sponsored by Unilever R&D evaluated the effect of plant sterols on blood lipid profiles in adults with Type 2 dia…

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Changing Diabetes® World Tour

The ClinicalTrials.gov study NCT01437072 sponsored by Novo Nordisk A/S has completed. It relates to diabetes mellitus type 1 and type 2.

CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

An observational trial sponsored by Novo Nordisk evaluates the effects of NovoMix 30, Levemir, and NovoRapid, used alone or in combination, …

Top drugs studied for this disease